427 related articles for article (PubMed ID: 23798713)
1. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.
Geddings JE; Mackman N
Blood; 2013 Sep; 122(11):1873-80. PubMed ID: 23798713
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice.
Thomas GM; Brill A; Mezouar S; Crescence L; Gallant M; Dubois C; Wagner DD
J Thromb Haemost; 2015 Jul; 13(7):1310-9. PubMed ID: 25955268
[TBL] [Abstract][Full Text] [Related]
3. Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.
Hisada Y; Ay C; Auriemma AC; Cooley BC; Mackman N
J Thromb Haemost; 2017 Nov; 15(11):2208-2217. PubMed ID: 28834179
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer.
Date K; Ettelaie C; Maraveyas A
J Thromb Haemost; 2017 Dec; 15(12):2289-2299. PubMed ID: 29028284
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer.
Wang JG; Geddings JE; Aleman MM; Cardenas JC; Chantrathammachart P; Williams JC; Kirchhofer D; Bogdanov VY; Bach RR; Rak J; Church FC; Wolberg AS; Pawlinski R; Key NS; Yeh JJ; Mackman N
Blood; 2012 Jun; 119(23):5543-52. PubMed ID: 22547577
[TBL] [Abstract][Full Text] [Related]
6. Microvesicles as risk markers for venous thrombosis.
Rautou PE; Mackman N
Expert Rev Hematol; 2013 Feb; 6(1):91-101. PubMed ID: 23373784
[TBL] [Abstract][Full Text] [Related]
7. Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays.
Hisada Y; Alexander W; Kasthuri R; Voorhees P; Mobarrez F; Taylor A; McNamara C; Wallen H; Witkowski M; Key NS; Rauch U; Mackman N
Thromb Res; 2016 Mar; 139():90-7. PubMed ID: 26916302
[TBL] [Abstract][Full Text] [Related]
8. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
9. Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one year.
Thaler J; Koppensteiner R; Pabinger I; Ay C; Gremmel T
Thromb Res; 2014 Nov; 134(5):1093-6. PubMed ID: 25262106
[TBL] [Abstract][Full Text] [Related]
10. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis.
Ramacciotti E; Hawley AE; Farris DM; Ballard NE; Wrobleski SK; Myers DD; Henke PK; Wakefield TW
Thromb Haemost; 2009 Apr; 101(4):748-54. PubMed ID: 19350121
[TBL] [Abstract][Full Text] [Related]
12. Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology.
Kleinjan A; Böing AN; Sturk A; Nieuwland R
Thromb Res; 2012 Oct; 130 Suppl 1():S71-3. PubMed ID: 23026670
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
[TBL] [Abstract][Full Text] [Related]
14. Microparticles and cancer thrombosis in animal models.
Mege D; Mezouar S; Dignat-George F; Panicot-Dubois L; Dubois C
Thromb Res; 2016 Apr; 140 Suppl 1():S21-6. PubMed ID: 27067974
[TBL] [Abstract][Full Text] [Related]
15. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
[TBL] [Abstract][Full Text] [Related]
16. The Release of Monocyte-Derived Tissue Factor-Positive Microparticles Contributes to a Hypercoagulable State in Idiopathic Membranous Nephropathy.
Wang GH; Lu J; Ma KL; Zhang Y; Hu ZB; Chen PP; Lu CC; Zhang XL; Liu BC
J Atheroscler Thromb; 2019 Jun; 26(6):538-546. PubMed ID: 30429407
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor positive microparticles as a biomarker for increased risk of breast cancer-associated thrombosis: a mini review.
Bucciol R; Othman M
Curr Opin Hematol; 2023 Sep; 30(5):180-185. PubMed ID: 37522480
[TBL] [Abstract][Full Text] [Related]
18. Role of tissue factor in hemostasis and thrombosis.
Mackman N
Blood Cells Mol Dis; 2006; 36(2):104-7. PubMed ID: 16466951
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.
Geddings JE; Hisada Y; Boulaftali Y; Getz TM; Whelihan M; Fuentes R; Dee R; Cooley BC; Key NS; Wolberg AS; Bergmeier W; Mackman N
J Thromb Haemost; 2016 Jan; 14(1):153-66. PubMed ID: 26516108
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor exposing microparticles in inflammatory bowel disease.
Palkovits J; Novacek G; Kollars M; Hron G; Osterode W; Quehenberger P; Kyrle PA; Vogelsang H; Reinisch W; Papay P; Weltermann A
J Crohns Colitis; 2013 Apr; 7(3):222-9. PubMed ID: 22705067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]